×
About 565 results

ALLMedicine™ Lichen Simplex Chronicus Center

Research & Reviews  95 results

Pediatric Atopic Dermatitis
https://emedicine.medscape.com/article/911574-overview

Jul 27th, 2022 - Practice Essentials Atopic dermatitis (AD) is a chronically relapsing skin disorder with an immunologic basis. [1] The clinical presentation varies from mild to severe. In the worst cases, atopic dermatitis may interfere with normal growth and dev...

Pediatric Atopic Dermatitis
https://emedicine.medscape.com/article/911574-print

Jul 27th, 2022 - Practice Essentials Atopic dermatitis (AD) is a chronically relapsing skin disorder with an immunologic basis.[1] The clinical presentation varies from mild to severe. In the worst cases, atopic dermatitis may interfere with normal growth and deve...

Pediatric Atopic Dermatitis
http://emedicine.medscape.com/article/911574-overview

Jul 27th, 2022 - Practice Essentials Atopic dermatitis (AD) is a chronically relapsing skin disorder with an immunologic basis. [1] The clinical presentation varies from mild to severe. In the worst cases, atopic dermatitis may interfere with normal growth and dev...

KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
https://clinicaltrials.gov/ct2/show/NCT05454462

Jul 12th, 2022 - This phase I study will be performed in patients with LSC instead of healthy subjects as in these patients, the significant histological changes (acanthosis and parakeratosis) result in heavily altered physiology and anatomy of the skin and any da...

Profile of Nonvenereal Female Genital Dermatoses: A Cross-Sectional Study From Eastern ...
https://doi.org/10.1097/LGT.0000000000000680
Journal of Lower Genital Tract Disease; Mondal S, Ghosh SK et. al.

Jun 29th, 2022 - Nonvenereal genital dermatoses may be a reason for considerable concern to the patient and often pose diagnostic dilemma to the treating physicians. The objective of the present study was to find out the demographical and clinical profile of nonve...

see more →

Guidelines  2 results

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Numb...
https://doi.org/10.1097/AOG.0000000000003945
Obstetrics and Gynecology;

Jun 27th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin, Number 224.
https://doi.org/10.1097/AOG.0000000000003944
Obstetrics and Gynecology;

Jun 27th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

see more →

Drugs  95 results see all →

Clinicaltrials.gov  3 results

KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
https://clinicaltrials.gov/ct2/show/NCT05454462

Jul 12th, 2022 - This phase I study will be performed in patients with LSC instead of healthy subjects as in these patients, the significant histological changes (acanthosis and parakeratosis) result in heavily altered physiology and anatomy of the skin and any da...

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
https://clinicaltrials.gov/ct2/show/NCT03858634

Dec 28th, 2021 - Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The diseases characterized by chronic pruritus investigated in this pilot study currently include c...

Dapsone Prurigo Study
https://clinicaltrials.gov/ct2/show/NCT01870050

Jun 5th, 2013 - Principal aim of this study is to assess whether a combination of topical dapsone and clobetasol as a topical steroid is superior to clobetasol alone as treatment of prurigo nodularis or lichen simplex chronicus in a side to side comparison. The s...

see more →

News  28 results

Three-Step Approach May Help Relieve One of the Itchiest Vulvar Conditions
https://www.medscape.com/viewarticle/937976

Sep 24th, 2020 - A three-step approach may help relieve itch in patients with lichen simplex chronicus, "one of the itchiest conditions that we ever see on the vulva," an expert advised at the virtual conference on diseases of the vulva and vagina, hosted by the I...

Three-Step Approach May Help Relieve One of the Itchiest Vulvar Conditions
https://www.staging.medscape.com/viewarticle/937976

Sep 24th, 2020 - A three-step approach may help relieve itch in patients with lichen simplex chronicus, "one of the itchiest conditions that we ever see on the vulva," an expert advised at the virtual conference on diseases of the vulva and vagina, hosted by the I...

Three-step approach may help relieve one of the itchiest vulvar conditions
https://www.mdedge.com/obgyn/article/228862/gynecology/three-step-approach-may-help-relieve-one-itchiest-vulvar-conditions
Jake Remaly

Sep 21st, 2020 - A three-step approach may help relieve itch in patients with lichen simplex chronicus, “one of the itchiest conditions that we ever see on the vulva,” an expert advised at the virtual conference on diseases of the vulva and vagina, hosted by the I.

Cutaneous T-cell Lymphoma and Concomitant Atopic Dermatitis Responding to Dupilumab
https://www.mdedge.com/dermatology/article/228390/atopic-dermatitis/cutaneous-t-cell-lymphoma-and-concomitant-atopic
Nicholas K. Mollanazar, MD, MBA, Kevin T. Savage, MD et. al.

Sep 11th, 2020 - Patients with cutaneous T-cell lymphoma (CTCL) often are diagnosed with atopic dermatitis (AD) or psoriasis before receiving their CTCL diagnosis. The effects of new biologic therapies for AD such as dupilumab, an IL-4/IL-13 antagonist, on CTCL ar.

Long-standing Dermatitis Treated With Dupilumab With Subsequent Progression to Cutaneous T-cell Lymphoma
https://www.mdedge.com/dermatology/article/227611/atopic-dermatitis/long-standing-dermatitis-treated-dupilumab-subsequent
L. Claire Hollins, MD, Paul Wirth, MD et. al.

Aug 27th, 2020 - Dupilumab is a novel medication that is approved by the US Food and Drug Administration to treat moderate to severe atopic dermatitis (AD) in patients 6 years and older. Dupilumab is an injectable fully human monoclonal antibody.

see more →

Patient Education  3 results see all →